Experimental Uses In experimental settings, it has also been studied for its potential neuroprotective and neuroregenerative effects
Here is a summary of early evidence and hypotheses for how they might work in treating Crohns disease
Short-acting formulations reach peak plasma concentrations within 1-3.5 hours and have shorter elimination half-lives, while long-acting agents like semaglutide have half-lives of approximately one week, allowing for sustained therapeutic effects
The peptide activates melanocortin-4 receptors in the hypothalamus and melanocortin-3 receptors in limbic circuits, triggering dopamine release and nitric oxide synthesis in arousal pathways
The pill format will likely increase the adoption of GLP-1 medications due to its lower pricing and convenience, with Novo Nordisks Wegovy pill being priced between $149 to $299 per month versus an average price of $1,000 per month for GLP-1 injectables, for example